Evaluation of fibroinflammatory activity in thyroid eye disease using [18F]AlF-NOTA-FAPI-04 PET/CT: A prospective study

被引:0
|
作者
Li, Hui [1 ]
Wang, Yi [2 ,3 ]
Zhou, Jichao [2 ,3 ]
You, Debo [2 ,3 ]
Song, Le [1 ]
Wang, Meng [1 ]
Zhao, Meixin [1 ]
Zhang, Chun [2 ,3 ]
Zhang, Yinghong [4 ]
Lin, Yansong [5 ]
Wu, Huanwen [6 ]
Liu, Zhaofei [1 ,7 ]
Wang, Ningli [8 ]
Zhang, Weifang [1 ]
Suo, Lingge [2 ,3 ]
机构
[1] Peking Univ, Hosp 3, Dept Nucl Med, Beijing, Peoples R China
[2] Peking Univ, Hosp 3, Dept Ophthalmol, Beijing, Peoples R China
[3] Peking Univ, Hosp 3, Beijing Key Lab Restorat Damaged Ocular Nerve, Beijing, Peoples R China
[4] Peking Univ, Hosp 3, Dept Otorhinolaryngol, Beijing, Peoples R China
[5] Peking Union Med Coll Hosp, Dept Nucl Med, Beijing, Peoples R China
[6] Peking Union Med Coll Hosp, Dept Pathol, Beijing, Peoples R China
[7] Peking Univ, Sch Basic Med Sci, Hlth Sci Ctr, Dept Radiat Med, Beijing, Peoples R China
[8] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Ophthalmol & Visual Sci Key Lab, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
Thyroid eye disease; Fibroblast activation protein inhibitor; Clinical activity score; Extraocular muscles; CLINICAL ACTIVITY SCORE; GRAVES OPHTHALMOPATHY; ORBITOPATHY; PATIENT;
D O I
10.1007/s00259-024-07015-y
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose This study evaluates the value of [F-18]AlF-NOTA-FAPI-04PET/CT in assessing the disease activity of thyroid eye disease (TED). Methods Twenty-three TED patients and ten healthy controls were prospectively recruited and underwent [F-18]AlF-NOTA-FAPI-04 PET/CT scans. TED eyes were classified by Clinical Activity Score (CAS) as active (CAS +) or inactive (CAS-). PET analysis included qualitative and quantitative evaluations. Qualitative analysis categorized TED eyes as positive (FAPI +) or negative (FAPI-), while quantitative analysis including SUVmax and target-to-backgroud ratio (TBR) of each extraocular muscle (EOM). Pathological assessment of 16 EOM samples from 15 TED eyes was used as a gold standard to evaluate the diagnostic accuracy of CAS-driven and FAPI-driven assessments. Results Eye-based analysis included 42 TED eyes and 20 control eyes. SUVmax did not differ significantly between CAS-/FAPI + (n = 8) and CAS + /FAPI + (n = 17) eyes; though both groups had significantly higher SUVmax than CAS-/FAPI- (n = 16), CAS + /FAPI- (n = 1), and control eyes (n = 20) (all P < .05). Diffuse high FAPI uptake with excellent TBR was observed in pathologically active EOMs and had higher SUVmax and TBR than inactive EOMs (SUVmax: 9.57 +/- 2.79 vs. 4.04 +/- 1.02, TBR: 2.99 +/- 1.00 vs. 1.00 +/- 0.35, both P < .001). An SUVmax cutoff value of 5.95 yielded an area under the receiver operating characteristic curve of 0.98 for predicting active disease. Sensitivity and specificity of CAS-driven and FAPI-driven assessments for TED activity were 72.7% and 100%, 100% and 100%, respectively. SUVmax positively correlated with pathological fibroinflammatory score (r = 0.68, P = .004). Conclusion The diffuse high FAPI uptake with excellent TBR in the EOMs could illustrate the activity of TED, positively correlated with pathological fibroinflammatory scores. These findings suggest that [F-18]AlF-NOTA-FAPI-04 PET/CT may serve as a promising reliable non-invasive approach for assessing disease activity in TED, potentially superior to the CAS.
引用
收藏
页码:1890 / 1900
页数:11
相关论文
共 50 条
  • [21] [18F]AlF-NOTA-FAPI-04 PET/CT uptake in metastatic lesions on PET/CT imaging might distinguish different pathological types of lung cancer
    Yuchun Wei
    Kai Cheng
    Zheng Fu
    Jinsong Zheng
    Zhengshuai Mu
    Chenglong Zhao
    Xiaoli Liu
    Shijie Wang
    Jinming Yu
    Shuanghu Yuan
    European Journal of Nuclear Medicine and Molecular Imaging, 2022, 49 : 1671 - 1681
  • [22] [18F]AlF-NOTA-FAPI-04 PET imaging of fibroblast activation protein in heart failure with preserved ejection fraction
    Sun, Fangfang
    Wang, Chengdong
    Du, Xuemei
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63
  • [23] Comparative assessment of the diagnostic efficacy of [18F]AlF-NOTA-FAPI-04 and [18F]FDG PET/CT imaging for detecting postoperative recurrence in gastric cancer patients: a pilot study
    Yang, Jian
    Wu, Yong
    Zhang, Yanyin
    Peng, Xiang
    Jiang, Chengzhi
    Zhou, Wanjing
    Dai, Jiashun
    Xie, Aimin
    Ye, Hui
    Zheng, Kai
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [24] he role of [18F] AlF-NOTA-FAPI-04 PET/CT for patients with digestive system malignancies: preliminary experience of comparative analysis with 18F-FDG
    Yang, Liping
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63
  • [25] Diffusely increased breast uptake of [18F]AlF-NOTA-FAPI-04 related to menstrual status in a patient with papillary thyroid cancer
    He, Tao
    Li, Xiangyu
    Liang, Changping
    Wu, Jie
    Cai, Huawei
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (07) : 2228 - 2229
  • [26] Diffusely increased breast uptake of [18F]AlF-NOTA-FAPI-04 related to menstrual status in a patient with papillary thyroid cancer
    Tao He
    Xiangyu Li
    Changping Liang
    Jie Wu
    Huawei Cai
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 2228 - 2229
  • [27] [18F] AlF-NOTA-FAPI-04 PET/CT as a promising tool for imaging fibroblast activation protein in gastrointestinal system cancers: a prospective investigation of comparative analysis with 18F-FDG
    Yang, Liping
    Xu, Shichuan
    Cheng, Liang
    Gao, Chao
    Cao, Shaodong
    Chang, Zhengsong
    Wang, Kezheng
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (13) : 4051 - 4063
  • [28] [18F] AlF-NOTA-FAPI-04 PET/CT can predict treatment response and survival in patients receiving chemotherapy for inoperable pancreatic ductal adenocarcinoma
    Zhu, Ziyuan
    Cheng, Kai
    Yun, Zhang
    Zhang, Xiang
    Hu, Xiaoyu
    Liu, Jing
    Wang, Fuhao
    Fu, Zheng
    Yue, Jinbo
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (11) : 3425 - 3438
  • [29] [18F] AlF-NOTA-FAPI-04 PET/CT can predict treatment response and survival in patients receiving chemotherapy for inoperable pancreatic ductal adenocarcinoma
    Ziyuan Zhu
    Kai Cheng
    Zhang Yun
    Xiang Zhang
    Xiaoyu Hu
    Jing Liu
    Fuhao Wang
    Zheng Fu
    Jinbo Yue
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 3425 - 3438
  • [30] [18F]AlF-NOTA-FAPI-04 PET/CT can predict treatment response and survival in patients esophageal squamous cell carcinoma treated with concurrent chemoradiotherapy
    Hu, X.
    Yu, J.
    Wei, Y.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S225 - S225